Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must have already received the treatment called BEAM-101 as part of a previous study called BTX-AUT-001, and be in the process of finishing that study's final visit.
- You must be willing and able to sign a written consent form agreeing to take part, following the rules set by the relevant ethics review board.
Who may not be able to join:
- There are no exclusion criteria for this study, meaning no specific reasons have been listed that would automatically prevent someone from joining.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 857-327-8641
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Long-Term Safety Monitoring and Mortality Assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.